
According to data from Benzinga Pro, during Q4, Neuronetics's (NASDAQ:STIM) reported sales totaled $15.02 million. Despite a 6.32% increase in earnings, the company posted a loss of $7.64 million. In Q3, Neuronetics brought in $13.80 million in sales but lost $8.15 million in earnings.